A股異動丨和晶科技漲近6% 實控人慾2.39億元轉讓控制權
格隆匯1月20日丨和晶科技(300279.SZ)漲近6%,報6.88元,總市值31億元。

1月13日晚間,和晶科技公告稱,控股股東、實控人陳柏林當天與公司第二大股東荊州慧和股權投資合夥企業(有限合夥)簽署《荊州慧和股權投資合夥企業(有限合夥)與陳柏林之股份轉讓協議》,陳柏林將其持有的公司2950萬股份轉讓給荊州慧和,轉讓價格2.39億元。在權益變動完成後,和晶科技的控股股東變更為荊州慧和。公司主要從事大型白色家電智能控制器的研發、生產和銷售,是國內最早將單片微型計算機(MCU)應用於家電智能控制領域的行業先行者之一。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.